LIVE Webinar: Finding the Right AML Treatment for Me

December 11, 2017



An online audience of AML patients and their caregivers joined us virtually for a recent webcast in association with the Patient Empowerment Network to hear the latest from leading experts about AML and personalized medicine.

We are also planning events in the future. If you haven’t already, please sign up for email updates so we can alert you when important and inspiring videos become available and when upcoming events are scheduled.


Chemo vs. Transplants: What Is the Purpose and Value of Each AML Treatment Method?

There are several treatment methods used for AML patients, but which one is right for you? AML expert Dr. Gwen Nichols gives information on procedure, purpose and value to help patients find the best approach.

Published:

How Likely Is It for a Patient's Myelofibrosis or MDS to Transform Into AML?

What percentage of people with MDS or an MPN transform into AML? Our expert panel explains the signs to look for and what tests are done for patient risk assessment.

Published:

When Should AML Patients Consider a Splenectomy?

AML expert Dr. Ross Levine explains why and when AML patients should consider getting a splenectomy. Tune in to learn more about AML treatment options.

Published:

AML Patient Insight: Resources to Consider to Help Reach Treatment Goals

How can AML patients establish a good foundation with their health care team and get the most out of doctor visits? Watch now to hear from our expert panel valuable tools for patients to use on their treatment journey.

Published:

CAR T-Cell Therapy’s Role in AML Treatment

Can AML patients benefit from CAR T-cell therapy? Which patients are a good candidate for this type of treatment? Watch now to hear our ASH 2017 panel of AML experts discuss the latest research.

Published:

Genetic Profiling: Identifying High-Risk and Low-Risk AML Patients

What can you learn about your AML condition from your genetic profile? AML expert Dr. Ross Levine joined us at ASH 2017 to share the latest research on how molecular characterization affects AML prevention, progression and treatment.

Published:

Know Your Diagnosis: How Do AML Cells Change Over Time?

How do AML cells arise and interact with the body? Watch as AML experts discuss the fundamental biology patients should know about their condition.

Published:

How Can I Find an AML Specialist?

Leukemia expert Dr. Gwen Nichols joined us at ASH 2017 to share a valuable resource for patients to use to access a specialist with extensive AML care experience and discover the full range of treatment options available.

Published:

How to Test for, Identify and Treat AML Subtypes

How many subtypes of AML are there? Are you getting the right testing done? AML expert Dr. Ross Levine joined us at ASH 2017 to discuss testing for subtypes and an individualized approach to treatment.

Published:

Showing 9 of 11 programs
Host & Guests
Host

Host, Patient Power Co-Founder, CLL Patient and Advocate


Guests

Laurence Joseph Dineen Chair in Leukemia Research

Memorial Sloan Kettering Cancer Center


Executive Vice President, Chief Medical Officer


AML Patient Advocate


This is a Patient Empowerment Network program produced by Patient Power, in partnership with The Leukemia & Lymphoma Society (LLS). We thank Astellas, Celgene Corporation, Novartis, Pfizer and Seattle Genetics for their support.

Patient Empowerment Network
The Leukemia & Lymphoma Society (LLS)
Patient Power
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on May 24, 2018